Pain management strategies for Cancer Pain

Phase-Based Progress Estimates
Brigham and Women's Hospital, Boston, MA
Cancer Pain
Early Referral - Other
All Sexes
What conditions do you have?

Study Summary

The purpose of the study is to evaluate how feasible and beneficial it is to refer patients with cancer pain to a doctor who specializes in pain management, including procedures to relieve pain, and whether this is helpful to patients with pain related to their cancer.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: 4 Weeks up to 4 months

Month 4
Pain Care Participation Rate
Pain Consultation Participation Rate
Satisfaction Ratings

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Pain management strategies
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Pain management strategies · No Placebo Group · N/A

Pain management strategiesExperimental Group · 2 Interventions: Early Referral, Pain Management Strategies · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks up to 4 months

Trial Background

Andrea Enzinger, Principal Investigator
Principal Investigator
Dana-Farber Cancer Institute
Closest Location: Brigham and Women's Hospital · Boston, MA
Photo of Boston  1Photo of Boston  2Photo of Boston  3
2008First Recorded Clinical Trial
2 TrialsResearching Cancer Pain
1041 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have persistent pain with an average pain rating of 4 or greater on an 11-point numeric rating scale (NRS) from 0-10 where 10 is considered the most severe.
You have a diagnosis of a metastatic, or locally advanced unresectable malignancy.
You have a life expectancy of more than 6 months.
You have pain that has persisted for at least 2 weeks.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.